Moderna Unusual Options Activity

Moderna Unusual Options Activity

Someone with a lot of money to spend has taken a bearish stance on Moderna MRNA.

And retail traders should know.

We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Whether this is an institution or just a wealthy individual, we don't know. But when something this big happens with MRNA, it often means somebody knows something is about to happen.

So how do we know what this whale just did?

Today, Benzinga's options scanner spotted 16 uncommon options trades for Moderna.

This isn't normal.

The overall sentiment of these big-money traders is split between 43% bullish and 56%, bearish.

Out of all of the special options we uncovered, 5 are puts, for a total amount of $244,895, and 11 are calls, for a total amount of $1,491,679.

What's The Price Target?

Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $110.0 to $250.0 for Moderna over the last 3 months.

Volume & Open Interest Development

In terms of liquidity and interest, the mean open interest for Moderna options trades today is 1193.83 with a total volume of 2,353.00.

In the following chart, we are able to follow the development of volume and open interest of call and put options for Moderna's big money trades within a strike price range of $110.0 to $250.0 over the last 30 days.

Moderna Option Volume And Open Interest Over Last 30 Days

Biggest Options Spotted:

 

Symbol PUT/CALL Trade Type Sentiment Exp. Date Strike Price Total Trade Price Open Interest Volume
MRNA CALL TRADE BULLISH 03/17/23 $170.00 $504.0K 691 183
MRNA CALL SWEEP NEUTRAL 01/13/23 $160.00 $260.0K 677 100
MRNA CALL SWEEP BEARISH 12/30/22 $160.00 $242.5K 850 90
MRNA PUT SWEEP BULLISH 06/16/23 $110.00 $128.0K 609 200
MRNA CALL SWEEP BULLISH 12/30/22 $160.00 $112.5K 850 278

Where Is Moderna Standing Right Now?

  • With a volume of 581,879, the price of MRNA is down -2.86% at $177.13.
  • RSI indicators hint that the underlying stock may be approaching overbought.
  • Next earnings are expected to be released in 80 days.

What The Experts Say On Moderna:

  • Chardan Capital has decided to maintain their Buy rating on Moderna, which currently sits at a price target of $186.

Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.

If you want to stay updated on the latest options trades for Moderna, Benzinga Pro gives you real-time options trades alerts.

Posted In: BZI-UOAOptionsMarkets